Skip to main navigation Skip to search Skip to main content

Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after ≥2 prior therapies

  • Laurie H. Sehn
  • , Nancy L. Bartlett
  • , Matthew J. Matasar
  • , Stephen J. Schuster
  • , Sarit E. Assouline
  • , Pratyush Giri
  • , John Kuruvilla
  • , Mazyar Shadman
  • , Chan Yoon Cheah
  • , Sascha Dietrich
  • , Keith Fay
  • , Matthew Ku
  • , Loretta J. Nastoupil
  • , Michael C. Wei
  • , Shen Yin
  • , Iris To
  • , Derrick Kaufman
  • , Antonia Kwan
  • , Elicia Penuel
  • , Christopher R. Bolen
  • Lihua E. Budde

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after ≥2 prior therapies'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology